Purchase Order HHSN302201700243P

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. for $10,114.00 on August 24, 2017. Performance is in North Bethesda, Maryland. The order is firm fixed price with no set-aside designation and completion is scheduled for September 23, 2017. The procurement covers reagents, kits, and scientific supplies supporting genomic research and DNA sequencing activities.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. for $16,344.40 on August 24, 2017. The order is firm fixed price with no set-aside designation. Place of performance is North Bethesda, Maryland. The order calls for reagents, kits, and scientific supplies to support genomic research and DNA sequencing. Ultimate completion is scheduled for September 23, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. valued at $24,855.40 on August 24, 2017. Performance occurs in North Bethesda, Maryland, with completion by September 23, 2017. The order is firm fixed price with no set-aside designation. Kapa Biosystems supplies reagents, kits, and scientific materials supporting genomic research and DNA sequencing operations.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. valued at $11,796.80 on August 14, 2019. Performance is located in Bethesda, Maryland. The order procures reagents, kits, and scientific supplies to support genomic research and DNA sequencing, with firm fixed pricing and ultimate completion by October 31, 2019.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. for $16,344.40 on August 7, 2017. No set-aside was used. Performance will take place in Bethesda, Maryland, with an ultimate completion date of September 6, 2017. The order is for reagents, kits, and scientific supplies supporting genomic research and DNA sequencing activities. The contract carries firm fixed price terms.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Kapa Biosystems, Inc. for $13,638.50 on September 19, 2017, with performance in Bethesda, Maryland. The order procures reagents, kits, and scientific supplies supporting genomic research and DNA sequencing. Ultimate completion is scheduled for December 15, 2017. Pricing is firm fixed price with no small business set-aside.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Kapa Biosystems, Inc. valued at $19,908.96 on October 30, 2019, for SEQCAP EZ Choice Library 24 RXN. Performance occurs in Castleton, Indiana. The order carries firm-fixed-price pricing with no set-aside designation and a completion date of December 31, 2019.</p>

This federal contract award was made by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Kapa Biosystems, Inc., a for-profit manufacturer of genomic research products. The $11,746.80 firm-fixed price contract is for the provision of reagents, kits, and other supplies to support genomic research and DNA sequencing activities. This award does not have a set-aside designation. Based on the vendor's past performance, Kapa...

<p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $11,190.00 on December 4, 2017, with completion scheduled for January 3, 2018. The order is firm fixed price with no small business set-aside. Work is performed in North Bethesda, Maryland. The purchase order procures sequencing consumables or reagent kits for genomic research operations.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences Of California, Inc. on July 7, 2017, for $4,525.00 under firm fixed-price terms. Work is to be performed in North Bethesda, Maryland, with an ultimate completion date of August 6, 2017. The purchase order covers sequencing consumables or reagents supporting the institute's genomic research operations.</p>